血管黏附蛋白-1在原发性硬化性胆管炎中升高,可预测临床结局,并以底物依赖方式促进肠道嗜性淋巴细胞向肝脏募集
研究探讨原发性硬化性胆管炎(PSC)中血管黏附蛋白-1(VAP-1)的表达、功能及酶激活。结果显示PSC肝内VAP-1酶活性升高,抑制VAP-1可减少肠道嗜性α4β7+淋巴细胞黏附,血清可溶性VAP-1升高独立且附加于肝硬化预测无移植生存。
要点
- PSC患者肝内VAP-1酶活性较免疫介导疾病对照及非病变肝脏升高(p<0.001)。
- VAP-1抑制剂氨基脲使肠道嗜性α4β7+淋巴细胞对肝内皮细胞黏附减少50%(p<0.01)。
- 血清可溶性VAP-1升高独立(HR 3.85,p=0.003)且附加于肝硬化(HR 2.02,p=0.012)预测较差无移植生存。
核心结论
- VAP-1在PSC中表达增加,以底物依赖方式促进肠道嗜性淋巴细胞黏附于肝内皮,其循环水平升高可预测患者临床结局。
研究设计与样本
- 研究检测PSC患者VAP-1表达,将水平与临床特征相关,并确定特定酶底物激活对肝内皮的功能后果;另以前瞻性评估的PSC患者队列分析血清可溶性VAP-1与无移植生存的关系。
主要发现
- PSC肝内VAP-1酶活性较免疫介导疾病对照和非病变肝脏升高(p<0.001)。
- 体外流动条件下,给予VAP-1抑制剂氨基脲后肠道嗜性α4β7+淋巴细胞对肝内皮细胞黏附减少50%(p<0.01)。
- 所测天然VAP-1底物中,半胱胺产酶速率最高且最能诱导肝内皮功能性黏膜地址素细胞黏附分子-1表达。
- 前瞻性PSC队列中,血清可溶性VAP-1升高独立(HR 3.85,p=0.003)且附加于肝硬化(HR 2.02,p=0.012)预测较差无移植生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of IBD. This clinical association is linked pathologically to the recruitment of mucosal T cells to the liver, via vascular adhesion protein (VAP)-1-dependent enzyme activity. Our aim was to examine the expression, function and enzymatic activation of the ectoenzyme VAP-1 in patients with PSC. DESIGN: We examined VAP-1 expression in patients with PSC, correlated levels with clinical characteristics and determined the functional consequences of enzyme activation by specific enzyme substrates on hepatic endothelium. RESULTS: The intrahepatic enzyme activity of VAP-1 was elevated in PSC versus immune-mediated disease controls and non-diseased liver (p<0.001). The adhesion of gut-tropic α4β7+lymphocytes to hepatic endothelial cells in vitro under flow was attenuated by 50% following administration of the VAP-1 inhibitor semicarbazide (p<0.01). Of a number of natural VAP-1 substrates tested, cysteamine-which can be secreted by inflamed colonic epithelium and gut bacteria-was the most efficient (yielded the highest enzymatic rate) and efficacious in its ability to induce expression of functional mucosal addressin cell adhesion molecule-1 on hepatic endothelium. In a prospectively evaluated patient cohort with PSC, elevated serum soluble (s)VAP-1 levels predicted poorer transplant-free survival for patients, independently (HR: 3.85, p=0.003) and additively (HR: 2.02, p=0.012) of the presence of liver cirrhosis. CONCLUSIONS: VAP-1 expression is increased in PSC, facilitates adhesion of gut-tropic lymphocytes to liver endothelium in a substrate-dependent manner, and elevated levels of its circulating form predict clinical outcome in patients.
引用
- Trivedi PJ, Tickle J, Vesterhus MN, et al. Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner. Gut. 2017. PMID: 28428344. doi:10.1136/gutjnl-2016-312354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。